Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Arovella Therapeutics ASX: ALA works in Biotechnology Research, out of Melbourne, Victoria. Publicly held, at arovella.com. It holds one address on record, all in Australia. It employs 23 people, on the record. It lists biotechnology and oncology among its specialties. The record links nine similar brands, most of them in Biotechnology Research.
Biotechnology, cell therapy, oncology, iNKT cell therapy, invariant natural killer T (iNKT) cell therapy platform, blood cancers, solid tumours, gastric & pancreatic cancers.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
23 counted staff profiles at January 2026, inside the self-reported 11–50 band.
One address on record, Australia only. Primary: 84 Hotham St, Melbourne, Victoria 3072.
None linked to this brand.
Eight tags on the brand's own list, among them biotechnology and oncology.
10 profiles list Arovella Therapeutics ASX: ALA as a peer — 82nd percentile in Biotechnology Research. It lists ten peers of its own. Chimeric Therapeutics and Carina Biotech list it back.